Who owns MOONLAKE IMMUNOTHERAPEUTICS?

Tip: Access positions for across all investors

Analyze quarterly positions in Moonlake Immunotherapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Moonlake Immunotherapeutics stock

Who bought or sold MOONLAKE IMMUNOTHERAPEUTICS this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Simplex Trading 203k $1.5M 1198% Sep 2025
 View chart
Group One Trading 166k $1.2M 507% Sep 2025
 View chart
Silverarc Capital Management 65k $466k 100% Sep 2025
 View chart
IMC-Chicago 54k $390k 100% Sep 2025
 View chart